Effective orally available drug combination of OR2100 and venetoclax in acute myeloid leukemia

被引：0
|
作者：
Ureshino, Hiroshi [1 ,2 ,3 ]
Watanabe, Tatsuro [2 ]
Kimura, Shinya [1 ,2 ]
机构：
[1] Saga Univ, Dept Hematol & Oncol, Saga, Japan
[2] Saga Univ, Dept Drug Discovery & Biomed Sci, Saga, Japan
[3] Hiroshima Univ, Res Inst Radiat Biol & Med, Higashihiroshima, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-1006
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [41] Benefit of the Reduced Dose Combination of Azacitidine and Venetoclax in an Elderly Patient With Acute Myeloid Leukemia
    Fujino, Keita
    Ureshino, Hiroshi
    Yoshida, Tetsumi
    Ichinohe, Tatsuo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [42] Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
    Jonas, Brian A.
    Wei, Andrew H.
    Recher, Christian
    DiNardo, Courtney D.
    Jang, Jun-Ho
    Pratz, Keith
    Panayiotidis, Panayiotis
    Montesinos, Pau
    Yeh, Su-Peng
    Ivanov, Vladimir
    Fiedler, Walter
    Yamauchi, Takahiro
    Duan, Yinghui
    Mendes, Wellington
    Potluri, Jalaja
    Tews, Bjorn
    Ofran, Yishai
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : E299 - E303
  • [43] The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19
    Cristiano, Antonio
    Palmieri, Raffaele
    Fabiani, Emiliano
    Ottone, Tiziana
    Divona, Mariadomenica
    Savi, Arianna
    Buccisano, Francesco
    Maurillo, Luca
    Tarella, Corrado
    Arcese, William
    Voso, Maria Teresa
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [44] Patterns of Sensitivity Exhibited By Venetoclax-Inclusive Drug Combinations in Acute Myeloid Leukemia
    Kurtz, Stephen E.
    Eide, Christopher A.
    Kaempf, Andy
    Long, Nicola
    Agarwal, Anupriya
    Tognon, Cristina E.
    Mori, Motomi
    Druker, Brian J.
    Tyner, Jeffrey W.
    BLOOD, 2019, 134
  • [45] Identifying effective drug combinations for patients with acute myeloid leukemia
    Yilmaz, Musa
    Kadia, Tapan
    Ravandi, Farhad
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 591 - 601
  • [46] More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine
    Aldoss, Ibrahim
    Marcucci, Guido
    CHINESE CLINICAL ONCOLOGY, 2019, 8
  • [47] Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
    Claudie Bosc
    Estelle Saland
    Aurélie Bousard
    Noémie Gadaud
    Marie Sabatier
    Guillaume Cognet
    Thomas Farge
    Emeline Boet
    Mathilde Gotanègre
    Nesrine Aroua
    Pierre-Luc Mouchel
    Nathaniel Polley
    Clément Larrue
    Eléonore Kaphan
    Muriel Picard
    Ambrine Sahal
    Latifa Jarrou
    Marie Tosolini
    Florian Rambow
    Florence Cabon
    Nathalie Nicot
    Laura Poillet-Perez
    Yujue Wang
    Xiaoyang Su
    Quentin Fovez
    Jérôme Kluza
    Rafael José Argüello
    Céline Mazzotti
    Hervé Avet-Loiseau
    François Vergez
    Jérôme Tamburini
    Jean-Jacques Fournié
    Ing S. Tiong
    Andrew H. Wei
    Tony Kaoma
    Jean-Christophe Marine
    Christian Récher
    Lucille Stuani
    Carine Joffre
    Jean-Emmanuel Sarry
    Nature Cancer, 2021, 2 : 1204 - 1223
  • [48] Venetoclax Dosing in Combination with Antifungal Agents: Real World Experience in Patients with Acute Myeloid Leukemia
    Rausch, Caitlin R.
    DiNardo, Courtney D.
    Maiti, Abhishek
    Jammal, Nadya
    Kadia, Tapan M.
    Marx, Kayleigh
    Borthakur, Gautam M.
    Savoy, J. Michael
    Pemmaraju, Naveen
    Dipippo, Adam
    Daver, Naval G.
    Chew, Serena
    Sasaki, Koji
    Issa, Ghayas C.
    Naqvi, Kiran
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Konopleva, Marina Y.
    BLOOD, 2019, 134
  • [49] ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms
    Mannelli, Francesco
    Guglielmelli, Paola
    Fazi, Paola
    Crea, Enrico
    Piciocchi, Alfonso
    Vignetti, Marco
    Amadori, Sergio
    Pane, Fabrizio
    Venditti, Adriano
    Vannucchi, Alessandro M.
    FUTURE ONCOLOGY, 2023, 19 (02) : 103 - 111
  • [50] Venetoclax in Combination with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia Is Comparable to Alternative Regimens
    Miller, Jenn
    Shannon, Lindsey
    Finch, Amanda
    Altman, Jessica K.
    Wojenski, Daniel
    BLOOD, 2020, 136
12345